Search research articles
Contact Us
Filters
Showing results (81-90 of 218) with videos related to
Page
of 22
Sort By:
The British Journal of Dermatology
|
May 14, 2011
Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study
J-H Saurat, R G Langley, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 30, 2019
Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis
R B Warren, J N W Barker, P Van de Kerkhof, et al.
Dermatology (Basel, Switzerland)
|
May 8, 2009
Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators
M A Radtke, K Reich, C Blome, et al.
The British Journal of Dermatology
|
September 14, 2011
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
J Barker, M Hoffmann, G Wozel, et al.
The Journal of Investigative Dermatology
|
February 17, 2001
Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation
K Reich, C Garbe, V Blaschke, et al.
The British Journal of Dermatology
|
February 1, 2007
Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis
K Kingo, R Mössner, S Kõks, et al.
Archives of Dermatological Research
|
September 12, 2015
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
K Reich, U Mrowietz, M A Radtke, et al.
The Journal of Investigative Dermatology
|
September 1, 1999
Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis
K Reich, G Westphal, T Schulz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2022
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3
K Reich, L Iversen, L Puig, et al.
In Vitro Cellular & Developmental Biology. Animal
|
July 1, 1997
Isolating and maintaining highly polarized primary epithelial cells from normal human duodenum for growth as spheroid-like vesicles
H J Boxberger, T F Meyer, M C Grausam, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 218) with videos related to
Sort By:
Page
of 22
The British Journal of Dermatology
|
May 14, 2011
Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study
J-H Saurat, R G Langley, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 30, 2019
Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis
R B Warren, J N W Barker, P Van de Kerkhof, et al.
Dermatology (Basel, Switzerland)
|
May 8, 2009
Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators
M A Radtke, K Reich, C Blome, et al.
The British Journal of Dermatology
|
September 14, 2011
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
J Barker, M Hoffmann, G Wozel, et al.
The Journal of Investigative Dermatology
|
February 17, 2001
Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation
K Reich, C Garbe, V Blaschke, et al.
The British Journal of Dermatology
|
February 1, 2007
Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis
K Kingo, R Mössner, S Kõks, et al.
Archives of Dermatological Research
|
September 12, 2015
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
K Reich, U Mrowietz, M A Radtke, et al.
The Journal of Investigative Dermatology
|
September 1, 1999
Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis
K Reich, G Westphal, T Schulz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2022
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3
K Reich, L Iversen, L Puig, et al.
In Vitro Cellular & Developmental Biology. Animal
|
July 1, 1997
Isolating and maintaining highly polarized primary epithelial cells from normal human duodenum for growth as spheroid-like vesicles
H J Boxberger, T F Meyer, M C Grausam, et al.
Page
of 22